143 related articles for article (PubMed ID: 8974793)
1. Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease.
Nsiri B; Gritli N; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
Hematol Cell Ther; 1996 Jul; 38(3):279-84. PubMed ID: 8974793
[TBL] [Abstract][Full Text] [Related]
2. Decreased protein S activity in sickle cell disease.
Marfaing-Koka A; Boyer-Neumann C; Wolf M; Leroy-Matheron C; Cynober T; Tchernia G
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):425-30. PubMed ID: 8414963
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor-positive monocytes expression in children with sickle cell disease: clinical implication and relation to inflammatory and coagulation markers.
Ragab SM; Soliman MA
Blood Coagul Fibrinolysis; 2016 Dec; 27(8):862-869. PubMed ID: 26761587
[TBL] [Abstract][Full Text] [Related]
4. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.
Noubouossie DF; Lê PQ; Corazza F; Debaugnies F; Rozen L; Ferster A; Demulder A
Am J Hematol; 2012 Feb; 87(2):145-9. PubMed ID: 22052675
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
7. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
8. Enhanced thrombin generation in children with sickle cell disease.
Peters M; Plaat BE; ten Cate H; Wolters HJ; Weening RS; Brandjes DP
Thromb Haemost; 1994 Feb; 71(2):169-72. PubMed ID: 8191393
[TBL] [Abstract][Full Text] [Related]
9. Coagulation changes in sickle cell disease in early childhood.
Babiker MA; Ashong EF; Bahakim H; Gader AM
Acta Haematol; 1987; 77(3):156-60. PubMed ID: 3113156
[TBL] [Abstract][Full Text] [Related]
10. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
11. Coagulation changes during the steady state in homozygous sickle-cell disease in Jamaica.
Leslie J; Langler D; Serjeant GR; Serjeant BE; Desai P; Gordon YB
Br J Haematol; 1975 Jun; 30(2):159-66. PubMed ID: 1201207
[TBL] [Abstract][Full Text] [Related]
12. Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy.
Colombatti R; De Bon E; Bertomoro A; Casonato A; Pontara E; Omenetto E; Saggiorato G; Steffan A; Damian T; Cella G; Teso S; Manara R; Rampazzo P; Meneghetti G; Basso G; Sartori MT; Sainati L
PLoS One; 2013; 8(10):e78801. PubMed ID: 24205317
[TBL] [Abstract][Full Text] [Related]
13. Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state.
Bayazit AK; Kilinç Y
Pediatr Int; 2001 Dec; 43(6):592-6. PubMed ID: 11737735
[TBL] [Abstract][Full Text] [Related]
14. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
15. Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls.
Hagger D; Wolff S; Owen J; Samson D
Blood Coagul Fibrinolysis; 1995 Apr; 6(2):93-9. PubMed ID: 7605884
[TBL] [Abstract][Full Text] [Related]
16. Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis.
Francis RB
Haemostasis; 1989; 19(2):105-11. PubMed ID: 2731776
[TBL] [Abstract][Full Text] [Related]
17. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic response to venous occlusion in patients with homozygous sickle cell disease.
Nsiri B; Gritli N; Mazigh C; Ghazouani E; Fattoum S; Machghoul S
Hematol Cell Ther; 1997 Oct; 39(5):229-32. PubMed ID: 9395896
[TBL] [Abstract][Full Text] [Related]
19. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
[TBL] [Abstract][Full Text] [Related]
20. Coagulation fibrinolysis in sickle-cell disease.
Gordon PA; Breeze GR; Mann JR; Stuart J
J Clin Pathol; 1974 Jun; 27(6):485-9. PubMed ID: 4412492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
